+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The laboratory assessment of partially treated acromegaly



The laboratory assessment of partially treated acromegaly



Journal of Endocrinology 139(SUPPL ): P123




(PDF emailed within 1 workday: $29.90)

Accession: 033856565

Download citation: RISBibTeXText


Related references

Clinical and laboratory study of acromegaly assessment before and 1 year after treatment. Qjm 43(171): 409-431, 1974

Clinical and laboratory study of acromegaly: assessment before and one year after treatment. Quarterly Journal of Medicine 43(171): 409-431, 1974

Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. European Journal of Endocrinology 154(5): 659-666, 2006

Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study. Journal of Endocrinological Investigation 31(8): 731-738, 2008

Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients. Endocrine 56(3): 589-594, 2017

Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. Journal of Endocrinological Investigation 34(1): 60-64, 2011

Accuracy assessment of cone beam computed tomography-derived laboratory-based surgical templates on partially edentulous patients. Clinical Oral Implants Research 23(2): 137-143, 2012

Evaluating Microtox as a tool for biodegradability assessment of partially treated solutions of pesticides using Fe3+ and TiO2 solar photo-assisted processes. Ecotoxicology and Environmental Safety 69(3): 546-555, 2007

Evaluating Microtox copyright as a tool for biodegradability assessment of partially treated solutions of pesticides using Fe3+ and TiO2 solar photo-assisted processes. 2008

Octreotide treatment in acromegaly: a comparison between pen-treated and pump-treated patients in a cross-over study. Acta Endocrinologica 125(1): 43-48, 1991

Role of overnight urinary growth hormone excretion and IGF-1 in the assessment of residual growth hormone secretion in treated acromegaly. Journal of Endocrinology 148(SUPPL ): P155, 1996

Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. European Journal of Endocrinology 159(5): 533-540, 2008

Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clinical Endocrinology 63(1): 103-110, 2005

Laboratory assessment of ammonia emission after soil application of treated and untreated manures. Journal of Agricultural Science 150(01): 65-73, 2012

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone. European Journal of Endocrinology 164(3): 325-333, 2011